产品简要
公司名称 :
Novus Biologicals
其他品牌 :
IMGENEX
产品类型 :
抗体
产品名称 :
EGLN3/PHD3抗体(EG188e/d5)
目录 :
NBP1-30440
规格 :
0.2 ml (also 0.05 ml)
价格 :
329美元
克隆性 :
单克隆
宿主 :
小鼠
共轭标签 :
未共轭
克隆名称 :
EG188e/d5
反应物种 :
人类, 大鼠
应用 :
免疫印迹, 免疫组化, 免疫组化-石蜡切片
更多信息或购买 :
文章摘录数: 10
出版应用/物种/样本/稀释参考文献
  • 免疫印迹; 大鼠
Fujita N, Gogate S, Chiba K, Toyama Y, Shapiro I, Risbud M. Prolyl hydroxylase 3 (PHD3) modulates catabolic effects of tumor necrosis factor-? (TNF-?) on cells of the nucleus pulposus through co-activation of nuclear factor ?B (NF-?B)/p65 signaling. J Biol Chem. 2012;287:39942-53 pubmed 出版商
  • 免疫组化-石蜡切片; 人类
Soilleux E, Turley H, Tian Y, Pugh C, Gatter K, Harris A. Use of novel monoclonal antibodies to determine the expression and distribution of the hypoxia regulatory factors PHD-1, PHD-2, PHD-3 and FIH in normal and neoplastic human tissues. Histopathology. 2005;47:602-10 pubmed
  • 免疫印迹; 人类
Appelhoff R, Tian Y, Raval R, Turley H, Harris A, Pugh C, et al. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem. 2004;279:38458-65 pubmed
Pavlakis D, Kampantais S, Gkagkalidis K, Gourvas V, Memmos D, Tsionga A, et al. Hypoxia-Inducible Factor 2a Expression Is Positively Correlated With Gleason Score in Prostate Cancer. Technol Cancer Res Treat. 2021;20:1533033821990010 pubmed 出版商
Capitanio D, Moriggi M, Torretta E, Barbacini P, De Palma S, Vigano A, et al. Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients. J Cachexia Sarcopenia Muscle. 2020;11:547-563 pubmed 出版商
Bur H, Haapasaari K, Turpeenniemi Hujanen T, Kuittinen O, Auvinen P, Marin K, et al. Strong Prolyl Hydroxylase Domain 1 Expression Predicts Poor Outcome in Radiotherapy-treated Patients with Classical Hodgkin's Lymphoma. Anticancer Res. 2018;38:329-336 pubmed
Zhang G, Yu F, Li Y, Wei Q, Song S, Zhou F, et al. Prolyl 4-Hydroxylase Domain Protein 3 Overexpression Improved Obstructive Sleep Apnea-Induced Cardiac Perivascular Fibrosis Partially by Suppressing Endothelial-to-Mesenchymal Transition. J Am Heart Assoc. 2017;6: pubmed 出版商
Kowalik M, Guzzo G, Morandi A, Perra A, Menegon S, Masgras I, et al. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis. Oncotarget. 2016;7:32375-93 pubmed 出版商
Mysore V, Szablowski J, Dervan P, FROST P. A DNA-binding Molecule Targeting the Adaptive Hypoxic Response in Multiple Myeloma Has Potent Antitumor Activity. Mol Cancer Res. 2016;14:253-66 pubmed 出版商
Stolze I, Tian Y, Appelhoff R, Turley H, Wykoff C, Gleadle J, et al. Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected]. J Biol Chem. 2004;279:42719-25 pubmed
产品信息
品牌 :
Novus
master code :
NBP1-30440
SKU号 :
NBP1-30440
产品名称 :
EGLN3/PHD3抗体(EG188e/d5)
描述 :
The EGLN3/PHD3 Antibody (EG188e/d5) from NBP1-30440 is a nbp1-30440 antibody to . This antibody reacts with apoptosis, cancer, hypoxia. The EGLN3/PHD3 Antibody (EG188e/d5) has been validated for the following applications: Q9H6Z9.
靶标 :
EGLN3/PHD3
类别 :
一抗
单位尺寸 :
0.2 ml (also 0.05 ml)
缓冲液 :
PBS
克隆性 :
单克隆
克隆 :
EG188e/d5
浓度 :
1毫克/毫升
共轭标签 :
未共轭
宿主 :
小鼠
免疫原 :
Partial recombinant human PHD3/HIF Prolyl Hydroxylase 3 (UniProt# Q9H6Z9)
抗体亚型 :
IgG1
纯度 :
蛋白质G纯化
物种 :
人类, 大鼠
理论上的分子量 :
27 kDa
基因符号 :
EGLN3
accessionNumbers :
Q9H6Z9
应用 :
Western Blot, Simple Western, Immunohistochemistry, Immunohistochemistry-Paraffin
美元 :
329美元
别名 :
EC 1.14.11, EC 1.14.11.-, EGL nine (C.elegans) homolog 3, egl nine homolog 3, egl nine homolog 3 (C. elegans), egl nine-like protein 3 isoform, FLJ21620, HIF prolyl hydroxylase 3, HIF-PH3, HIFPH3 MGC125998, HIF-prolyl hydroxylase 3, HPH-1, HPH-3, Hypoxia-inducible factor prolyl hydroxylase 3, MGC125999, pdh3, PHD3, Prolyl hydroxylase domain-containing protein 3
储存 :
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
更多信息或购买 :
公司信息
Novus Biologicals
8100 Southpark Way, A-8
Littleton, CO 80120
technical@novusbio.com
https://www.novusbio.com
1-888-506-6887 303-730-1950
公司总部: 美国
Novus Biologicals的任务是开发最先进的新产品及市场行销来加速生物科研的新发现。藉由高效率的组织分工,Novus Biologicals建立了一个将生物学术团体的成果快速商品化的平台。我们的产品除了附有详细的产品资讯外,Novus Biologicals更提供完整的技术支援及服务。利用快速有效的市场通路以便迅速提供所有的科研学者最先进的研究试剂,Novus Biologicals扮演市场上重要的角色。